2005P-0411 | Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs | |||||||||||||||||||||||
FDA Comment Number : | EC1603 | |||||||||||||||||||||||
Submitter : | Ms. Barbara Mikitin | Date & Time: | 02/13/2006 12:02:40 | |||||||||||||||||||||
Organization : | Ms. Barbara Mikitin | |||||||||||||||||||||||
Category : | Individual Consumer | |||||||||||||||||||||||
Issue Areas/Comments | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
Wyeth, the maker of Premarin and Prempro, filed a "Citizens Complaint" with the FDA on October 16, 2005, requesting that the FDA effectively prohibit compounding pharmacies from providing bio-identical hormones to their patients. I am strongly opposed to Wyeth's complaint. This is a compnay with no conscience. We should not be denied the choice of bioidentical hormone replacement therapy. | ||||||||||||||||||||||||